CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction" Baseline Features of the VICTORIA (Vericiguat Global Study in Subjects With Heart Failure With Reduced Ejection Fraction) Trial Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology: A Detailed Invasive Hemodynamic and Echocardiographic Analysis The year in cardiology: heart failure: The year in cardiology 2019 Is Cardiac Diastolic Dysfunction a Part of Post-Menopausal Syndrome? Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure Guideline‐Directed Medical Therapy for Patients With Heart Failure With Midrange Ejection Fraction: A Patient‐Pooled Analysis From the KorHF and KorAHF Registries
|<<... 4 5 6 7 8 9 10 ...>>|

Clinical TrialVolume 73, Issue 1, January 2019

JOURNAL：J Am Coll Cardiol. Article Link

Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and Women

P Dewan, R Rørth, JJV McMurray et al. Keywords: HFrEF; gender; comorbidity; mortality; quality of life

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top